Twist Bioscience Corporation

NasdaqGS:TWST Stock Report

Mkt Cap: US$1.5b

Twist Bioscience Financial Health

How is Twist Bioscience's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: TWST's short term assets ($541.9M) exceed its short term liabilities ($83.8M).

Long Term Liabilities: TWST's short term assets ($541.9M) exceed its long term liabilities ($79.8M).

Debt to Equity History and Analysis

Debt Level: TWST is debt free.

Reducing Debt: TWST has no debt compared to 5 years ago when its debt to equity ratio was 12.1%.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TWST has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: TWST has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 25.8% each year

Discover healthy companies